News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Photo of Dr. Hagop Kantarjian from obroncology.com
Apr 20, 2024, 07:03

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Dasatinib and Venetoclax is safe and effective in newly diagnosed Chronic Myeloid Leukaemia in CP, but no better than single-agent Dasatinib, longer follow-up needed to evaluate impact on TFR.”

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Additional information.
Source: Hagop Kantarjian/X

 

cancer chronic myeloid leukaemia CML Dasatinib Hagop Kantarjian MD Anderson Cancer Center OncoDaily Oncology TFR The University of Texas venetoclax
Special Coverage
Blog
Jul 18, 2025, 16:28
Talha Badar: Ruxolitinib Combined with Dexamethasone for Newly Diagnosed Adult Hemophagocytic Lymphohistiocytosis in China
Insight
Jul 18, 2025, 16:23
Leon Kaulen: The First Comprehensive Characterization of TIAN Arising in CNS Lymphoma
Blog
Jul 18, 2025, 16:15
Al-Ola A Abdallah: How BMI Affects Outcomes After Allogeneic Hematopoietic Stem Cell Transplant for AL and MDS
Blog
Jul 18, 2025, 16:05
Guest Editing a Special Issue on Lung Cancer - Submit Your Work!
Blog
Jul 18, 2025, 16:03
Mohamed Emam Sobeih: Don’t Miss ICONC 2025 - Egypt Cancer Support Foundation’s First Annual Conference
Science
Jul 18, 2025, 15:59
Ilyas Sahin: The Role of CLDN18.2-targeting ADC in Refractory Advanced GEJ Cancer Patients
Blog
Jul 18, 2025, 15:57
Jill Feldman: Calling All Thoracic Oncology Leaders to Join Us at the 7th Annual EGFR Resisters Research Summit
Science
Jul 18, 2025, 15:51
Nancy Lin: Palazestrant Demonstrates More Than 7 Months mPFS in EMERALD-Eligible ER+ MBC Patients
Blog
Jul 18, 2025, 15:45
Sumanta Pal: Ruchi Agarwal Presented Her Work on International Kidney Cancer Trial Availability
Blog
Jul 18, 2025, 15:43
Belén Garijo: Did You Know The Word “mentor” Originates From Homer’s Epic Poem The Odyssey?
Blog
Jul 18, 2025, 15:36
Olivier Elemento: Great Pleasure to Host Dr. Parsa Mirhaji And Adil Ahmed at The Englander Institute for Precision Medicine
Blog
Jul 18, 2025, 15:32
Vincent Rajkumar: ODAC Votes Against Belantamab Risk-Benefit for Myeloma